MDR-1339
MDR-1339 is a small molecule capable of crossing the blood-brain barrier to inhibit the aggregation of amyloid-β (Aβ) peptides. This property makes it a valuable research tool for investigating Aβ pathology in both cellular assays and animal models of Alzheimer's disease.
Product Specifications
CAS Number
1018946-38-7
Product Name Alternative
β Amyloid, βAmyloid, β-amyloid peptide, Beta Amyloid, BetaAmyloid, DWK-1339, DWK 1339, DWK1339, Abeta, bAmyloid, Amyloid-β, b Amyloid, Aβ, inhibit, MDR1339, MDR-1339, MDR 1339, Inhibitor, Gammasecretase
Field of Research
Neuroscience, Protein Biochemistry, Stem Cell & Developmental Biology
Purity
98.57% (May vary between batches)
Solubility
DMSO:40 mg/mL (122.55 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (6.13 mM)
Smiles
COCCCc1ccc2oc (cc2c1) -c1ccc (OC) c (OC) c1
Molecular Formula
C20H22O4
Molecular Weight
326.39
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb994560 100 µL
Phospho-FRA1 (Ser265) Rabbit Polyclonal Antibody (APC)
Sign In for Pricing
View Details 
GTR15381882 1 Vial
Lentiviral human HLCS sgRNA gene knockout kit - Lentiviral human HLCS sgRNA gene knockout kit (25)
Sign In for Pricing
View Details